Annotation Detail for MMP26

Basic Information
Top
Desease ID | Desease Name |
---|
1934 | Cancer |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of MMP26 mRNA | decreases expression | 20106945
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of MMP26 mRNA | decreases expression | 16984259
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.07 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.90 | 6695378 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
4.02 | 15955085 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.84 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.35 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.34 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.45 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
5.08 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
4.16 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.06 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.06 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
5.48 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
6.23 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
1.92 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.93 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.93 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.34 | 17460283 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
5.48 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
6.23 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.83 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
4.47 | 17035595 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 8800419 17551590 9664655 10589399 9125849 16925845 9142499 9211117 14991402 9224671 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
5.54 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.40 | 16569247 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.09 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.94 | 9664655 16938888 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
4.27 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.30 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.49 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
6.23 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
7.39 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
7.39 | 14991402 9664655 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.62 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
5.33 | 16778211 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.53 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.45 | 17551590 15992940 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.97 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
4.25 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.13 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.45 | 17368321 19642359 17107899 19075265 16935935 17339181 16140955 9834237 17301526 16788101 17217047 12679006 16331271 16823087 15748426 17649720 16766008 17361223 19029980 17294898 19225113 16891316 17506722 19035177 17712046 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.65 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
2.18 | 20195826 21137059 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
1.57 | 20064080 18816296 17053015 18569708 6695378 20464547 20135361 20869020 18520028 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.93 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.99 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
5.19 | 16940565 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.57 | 16381670 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.32 | 17596541 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
5.67 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.67 | 16594593 16946489 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.45 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.35 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.46 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.33 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.59 | 15976015 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.90 | 17292933 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
4.21 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.68 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.71 | 16283617 16116481 |
MESH:D012871 |
Skin Diseases |
marker/mechanism |
|
| 16984259 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
6.32 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.32 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.43 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.43 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.40 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.29 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.50 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
2.32 | 17053015 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
4.18 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.68 | 16752155 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.73 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.44 | 16287080 |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB00786 |
antagonist |
Marimastat |
Antineoplastic Agents;Enzyme Inhibitors |